Bright Green Corp

Bright Green Corp. engages in the cultivation, manufacture, and sale of medical cannabis. It focuses on the research and development of cannabis strains and sales of products with cannabinol (CBN) and cannabigerol (CBG). The company was founded by Lynn Stockwell on April 16, 2019 and is headquartered in Fort Lauderdale, FL.

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Bright Green Corp. engages in the cultivation, manufacture, and sale of medical cannabis. It focuses on the research and development of cannabis strains and sales of products with cannabinol and cannabigerol. The company was founded by Lynn Stockwell on April 16, 2019 and is headquartered in Grants, NM.

GRANTS, N.M., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export, today provided an update on progress on the execution of its business plan and the developments ahead for 2023.

Bright Green Provides Update on Progress as It Prepares for Multiple Activities in 2023

Bright Green reaches several key milestones, advancing progress against its strategic plan

Bright Green Announces Third Quarter 2022 Financial Update and Milestone Progress

Expansion of Bright Green's Scientific Advisory Board supports its mission to be the premier federally-authorized provider of cannabis and derivative products Expansion of Bright Green's Scientific Advisory Board supports its mission to be the premier federally-authorized provider of cannabis and derivative products

Bright Green Strengthens its Scientific Advisory Board with the Appointment of Five Additional Biotech and Pharmaceutical Leaders

Bright Green acquired 25% of Alterola's issued and outstanding common stock

Bright Green Announces Close of Transaction with Alterola Biotech

U.S. Drug Enforcement Agency Visit and Audit Completed

Bright Green Provides Progress Update on its Agricultural Complex in Grants, New Mexico

GRANTS, N.M., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export, today announced the closing of its previously announced private placement of common stock and warrants.

Bright Green Announces Closing of $10.0 Million Private Placement

GRANTS, N.M., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export, today announced that it has entered into a securities purchase agreement with institutional investors to purchase 9,523,810 shares of common stock and warrants to purchase 9,523,810 shares of common stock, at a purchase price of $1.05 per share and accompanying warrant. The gross proceeds to the Company from the private placement are expected to be approximately $10.0 million before deducting the placement agent's fees and other estimated offering expenses.

Bright Green Announces Pricing of $10.0 Million Private Placement

Investors take some time to decide that they like the company's new attempt at expanding its business.

Why Bright Green Stock Was a Hot "Go" Stock Today

Volcon

Virax Biolabs Group Ltd

Penny stocks to buy for under $5 but are they worth the risk? The post 3 Hot Penny Stocks To Buy For Under $5 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Hot Penny Stocks To Buy For Under $5 Right Now

Bright Green to acquire 25% of Alterola common stock, followed by proposed acquisition of all remaining Alterola common stock, subject to customary conditions and regulatory and stockholder approvals

Bright Green Signs Letter of Intent with Alterola Biotech for Strategic Partnership and Acquisition

Second Quarter Results and Favorable Liquidity Position Set the Stage for Growth in Fiscal Year 2023 and Beyond Second Quarter Results and Favorable Liquidity Position Set the Stage for Growth in Fiscal Year 2023 and Beyond

Bright Green Announces Second Quarter 2022 Financial Update and Milestone Progress

Staffing 360 Solutions

With the US stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Bright Green Corporation (NASDAQ: BGXX) disclosed that the CEO Ed Robinson is stepping down, while the company's board has named Chairman of the Board,.

Bright Green, Staffing 360 Solutions And 3 Stocks To Watch Heading Into Tuesday

Ed Robinson to step down; Terry Rafih, Bright Green's Chairman of the Board, to assume interim position as CEO

Bright Green Announces CEO Transition

StealthGas

23andMe

Check these three penny stocks out for your watchlist The post Best Penny Stocks to Watch in the Second Half of June appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Best Penny Stocks to Watch in the Second Half of June

Is this the industry's watershed moment, or is this just a one-off exception?

This Cannabis Stock Just Made History

China Liberal Education Holdings 

DecisionPoint Systems

NeuroMetrix

Visionary Education Technology Holdings Group Inc

A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It is a measure put in place to help restore and bring order to the markets.

6 Stocks Halted In Thursday's Session: Here's Why

Stockholders of Bright Green have offered to sell up to 158.2 million shares.

Bright Green Stock Makes Its Trading Debut. Here's How It Did.

GRANTS, N.M., May 16, 2022 (GLOBE NEWSWIRE) -- Bright Green Corporation (“Bright Green”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export, today announced that it expects that trading of its common stock on Nasdaq will commence on May 17, 2022 under the symbol “BGXX.”

Bright Green to Commence Trading on Nasdaq on May 17, 2022

GRANTS, N.M., May 04, 2022 (GLOBE NEWSWIRE) -- Bright Green Corporation (“Bright Green”), one of the very few companies selected by the US government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export, today announced that it will hold a virtual Investor Day on May 5, 2022, at 2 p.m. EDT. Registration and webcast details are available at this link.

Bright Green Announces Investor Day

Bright Green Corporation has filed initial information for a direct listing on the Nasdaq Capital Market.

Bright Green Files For U.S. Direct Listing

Bright Green Corp., a Fort Lauderdale, Fla.-based company with conditional approval from the U.S. Drug Enforcement Administration (DEA) to produce federally legal cannabis, on Tuesday filed plans to directly list its shares for trading on the Nasdaq under the ticker symbol “BGXX”.

Cannabis Watch: Cannabis company that DEA is allowing to grow for research purposes to list shares on Nasdaq

Bright Green Corp., a Fort Lauderdale, Fla.-based company with conditional approval from the U.S. Drug Enforcement Administration (DEA) to produce federally legal cannabis, on Tuesday filed plans to directly list its shares on the Nasdaq under the ticker symbol "BGXX".

Bright Green Corp. files plans to directly list shares on the Nasdaq as a DEA-licensed pot grower

GRANTS, N.M., March 29, 2022 (GLOBE NEWSWIRE) -- Bright Green Corporation (“Bright Green”), one of the very few companies selected by the US government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and export, today announced it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to the proposed direct listing of its common stock. Bright Green has applied to list its common stock with The Nasdaq Stock Market under the ticker symbol "BGXX.”

News for Bright Green Corp Stock (BGXX)